Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Jes B Hansen"'
Autor:
Jean-Philippe Lacour, Anthony Bewley, Edward Hammond, Jes B. Hansen, Laura Horne, Carle Paul, Kristian Reich, Julien Seneschal, Clara De Simone, Anne Sohrt, Matthias Augustin, Giovanni Pellacani
Publikováno v:
Dermatology and Therapy, Vol 10, Iss 5, Pp 1099-1109 (2020)
Abstract Introduction Clinical trials have shown that psoriasis patients who achieve complete skin clearance are more likely to report no impairment in health-related quality of life (HRQoL) and no psoriasis symptoms versus patients who achieve almos
Externí odkaz:
https://doaj.org/article/b80a78872dd94a85b046ef5c90307086
Publikováno v:
Psoriasis: Targets and Therapy
Philip Hampton,1 Emma Borg,2 Jes Birger Hansen,2 Matthias Augustin3 1Department of Dermatology, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK; 2LEO Pharma A/S, Ballerup, Denmark; 3Institute for Health Services Research in Derm
Publikováno v:
Journal of Drugs in Dermatology. 20:822-828
Background Psoriasis vulgaris is not easy to manage, even when mild. Knowledge of the efficacy of most topical therapies in this population is limited. Objective To assess the efficacy of calcipotriene 0.005% plus betamethasone dipropionate 0.064% (C
Autor:
Anne Sohrt, Anthony Bewley, Jean-Philippe Lacour, Kristian Reich, Carle Paul, Matthias Augustin, Clara De Simone, Edward R Hammond, Giovanni Pellacani, Julien Seneschal, Jes B Hansen, Laura Horne
Publikováno v:
Dermatology and Therapy, Vol 10, Iss 5, Pp 1099-1109 (2020)
Dermatology and Therapy
Dermatology and Therapy
Introduction Clinical trials have shown that psoriasis patients who achieve complete skin clearance are more likely to report no impairment in health-related quality of life (HRQoL) and no psoriasis symptoms versus patients who achieve almost complet
Publikováno v:
Journal of the American Academy of Dermatology. 83:131-138
Background The product of the Physician Global Assessment and body surface area (PGA×BSA) is simpler to use than the Psoriasis Area and Severity Index (PASI), which lacks sensitivity in patients with mild psoriasis. Objective To compare the PGA×BSA
Publikováno v:
Dermatology and Therapy
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Introduction Obesity, smoking, and alcohol consumption are prevalent in psoriasis patients and have been associated with increased disease severity and reduced treatment adherence and response. This post hoc analysis of pooled data from the phase 3 A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e5b9d3edf6d951da7d908168bb06837
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1610
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1610
Autor:
Natalia M. Stelmaszuk-Zadykowicz, Jes B Hansen, Lars-Åke Levin, Jonatan Freilich, Marcus Schmitt-Egenolf, Eydna Didriksen Apol
Publikováno v:
Dermatology and Therapy
Introduction Biologic treatments for psoriasis are commonly switched. Treatment persistence represents an important parameter related to long-term therapeutic performance. The objective of the study was to analyse the real-world persistence with biol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaec66780dae3c3f0d478bee4b96bb0e
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-180714
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-180714
Publikováno v:
Journal of drugs in dermatology : JDD. 19(8)
Background: Real-world data for actinic keratosis treatment in the United States is lacking. Objectives: To understand real-world treatment patterns for actinic keratosis by type and modality, and compare effectiveness and safety of therapies, either
Autor:
Dharm S, Patel, Karen A, Veverka, Jes B, Hansen, Paul S, Yamauchi, Javier, Alonso-Llamazares, Mark, Lebwohl
Publikováno v:
J Clin Aesthet Dermatol
BACKGROUND: There are a variety of treatment options currently available for plaque psoriasis affecting the scalp, yet scalp psoriasis remains one of the most frustrating and difficult-to-manage forms of the disease. OBJECTIVE: We investigated the ef
Publikováno v:
Journal of medical economics. 23(6)
Background: The fixed-dose combination foam formulation of calcipotriene 0.005% plus betamethasone dipropionate 0.064% (Cal/BD) has demonstrated efficacy and a favorable safety profile for the treatment of plaque psoriasis. Recently, a topical lotion